Alto Ingredients (ALTO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy).
Investors might want to bet on Intensity Therapeutics Inc. (INTS), as it has been recently upgraded to a Zacks Rank #2 (Buy).
Alibaba Group Holding's BABA ambitious infrastructure expansion threatens to further erode profitability as the company locks ...
Abbott Laboratories ABT recently announced that Lingo, its first over-the-counter biowearable continuous glucose monitor ...
Ooma (OOMA) closed the last trading session at $11.88, gaining 4.6% over the past four weeks, but there could be plenty of ...
Shares of Welltower WELL have gained 48.1% year to date, outperforming the industry’s upside of 5.2%. Welltower boasts a well ...
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks ...
Kinross Gold Corporation’s KGC shares hit a fresh 52-week high of $29.23 last Friday, before retracing to close the session ...
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even ...
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock ...
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell ...
Werewolf Therapeutics, Inc. (HOWL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results